EVI2B | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
B cell	34 studies	41% ± 15%	Explore
macrophage	26 studies	33% ± 13%	Explore
natural killer cell	25 studies	26% ± 7%	Explore
classical monocyte	25 studies	55% ± 21%	Explore
non-classical monocyte	23 studies	54% ± 25%	Explore
conventional dendritic cell	22 studies	42% ± 16%	Explore
CD8-positive, alpha-beta T cell	21 studies	28% ± 8%	Explore
monocyte	18 studies	43% ± 17%	Explore
memory B cell	18 studies	42% ± 18%	Explore
CD4-positive, alpha-beta T cell	18 studies	32% ± 12%	Explore
T cell	16 studies	30% ± 8%	Explore
dendritic cell	15 studies	40% ± 24%	Explore
regulatory T cell	15 studies	27% ± 10%	Explore
plasma cell	14 studies	37% ± 16%	Explore
naive B cell	14 studies	39% ± 14%	Explore
neutrophil	12 studies	40% ± 16%	Explore
gamma-delta T cell	12 studies	28% ± 8%	Explore
mature NK T cell	11 studies	28% ± 8%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	10 studies	34% ± 13%	Explore
plasmacytoid dendritic cell	10 studies	32% ± 8%	Explore
mast cell	9 studies	25% ± 6%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	9 studies	30% ± 12%	Explore
leukocyte	8 studies	33% ± 8%	Explore
CD16-positive, CD56-dim natural killer cell, human	7 studies	23% ± 6%	Explore
T follicular helper cell	7 studies	34% ± 15%	Explore
mucosal invariant T cell	7 studies	23% ± 4%	Explore
myeloid cell	7 studies	45% ± 15%	Explore
CD8-positive, alpha-beta memory T cell	7 studies	34% ± 10%	Explore
alveolar macrophage	6 studies	50% ± 21%	Explore
effector memory CD8-positive, alpha-beta T cell	6 studies	34% ± 7%	Explore
innate lymphoid cell	6 studies	26% ± 6%	Explore
mononuclear phagocyte	5 studies	46% ± 20%	Explore
microglial cell	5 studies	30% ± 13%	Explore
CD4-positive helper T cell	5 studies	32% ± 11%	Explore
CD4-positive, alpha-beta memory T cell	5 studies	31% ± 9%	Explore
effector memory CD4-positive, alpha-beta T cell	5 studies	36% ± 13%	Explore
hematopoietic precursor cell	4 studies	29% ± 7%	Explore
plasmablast	4 studies	39% ± 15%	Explore
IgA plasma cell	4 studies	29% ± 12%	Explore
IgG plasma cell	4 studies	22% ± 3%	Explore
platelet	3 studies	26% ± 7%	Explore
monocyte-derived dendritic cell	3 studies	48% ± 25%	Explore
CD16-negative, CD56-bright natural killer cell, human	3 studies	24% ± 4%	Explore
thymocyte	3 studies	26% ± 9%	Explore
intraepithelial lymphocyte	3 studies	24% ± 5%	Explore
germinal center B cell	3 studies	27% ± 9%	Explore
intermediate monocyte	3 studies	66% ± 20%	Explore
T-helper 17 cell	3 studies	32% ± 7%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	3 studies	19% ± 1%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	15 studies	39% ± 16%	Explore
lung	9 studies	24% ± 6%	Explore
brain	4 studies	21% ± 7%	Explore
intestine	3 studies	27% ± 8%	Explore
lymph node	3 studies	26% ± 13%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	3279.61	578 / 578	93%	30.42	1074 / 1155
breast	71%	473.01	324 / 459	94%	25.99	1048 / 1118
intestine	80%	1331.52	772 / 966	72%	15.27	382 / 527
stomach	69%	424.34	248 / 359	78%	23.16	222 / 286
bladder	71%	552.90	15 / 21	63%	11.68	316 / 504
esophagus	47%	258.41	686 / 1445	85%	18.39	155 / 183
prostate	68%	458.79	167 / 245	64%	7.99	320 / 502
brain	37%	254.55	973 / 2642	90%	23.29	638 / 705
skin	44%	457.07	790 / 1809	82%	25.07	389 / 472
thymus	48%	443.38	316 / 653	78%	21.65	470 / 605
kidney	33%	282.15	29 / 89	87%	26.36	788 / 901
uterus	36%	170.89	62 / 170	72%	11.89	331 / 459
lymph node	0%	0	0 / 0	100%	116.10	29 / 29
peripheral blood	100%	38388.06	929 / 929	0%	0	0 / 0
spleen	100%	9511.36	241 / 241	0%	0	0 / 0
adrenal gland	62%	322.38	160 / 258	37%	3.53	84 / 230
pancreas	11%	63.83	35 / 328	88%	25.52	156 / 178
ovary	15%	78.05	27 / 180	81%	16.84	350 / 430
adipose	94%	1064.33	1134 / 1204	0%	0	0 / 0
liver	37%	173.18	84 / 226	48%	6.92	196 / 406
tonsil	0%	0	0 / 0	84%	26.81	38 / 45
blood vessel	58%	503.93	769 / 1335	0%	0	0 / 0
heart	27%	143.79	234 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	16%	2.41	13 / 80
muscle	1%	5.95	11 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_0030854	Biological process	positive regulation of granulocyte differentiation
GO_0043066	Biological process	negative regulation of apoptotic process
GO_0045660	Biological process	positive regulation of neutrophil differentiation
GO_2000035	Biological process	regulation of stem cell division
GO_0051726	Biological process	regulation of cell cycle
GO_0061515	Biological process	myeloid cell development
GO_0005886	Cellular component	plasma membrane

IV. Literature review

[source]

Gene name	EVI2B
Protein name	Protein EVI2B (Ecotropic viral integration site 2B protein homolog) (EVI-2B) (CD antigen CD361) Ecotropic viral integration site 2B
Synonyms	EVDB
Description	FUNCTION: Required for granulocyte differentiation and functionality of hematopoietic progenitor cells through the control of cell cycle progression and survival of hematopoietic progenitor cells. .
Accessions	ENST00000708441.1 [P34910-1] ENST00000708442.1 [P34910-1] ENST00000330927.5 [P34910-1] Q9BRW1 ENST00000577894.1 [P34910-1] P34910

EVI2B report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review